Emergent BioSolutions (NYSE:EBS – Get Free Report) and Avid Bioservices (NASDAQ:CDMO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership. Analyst Recommendations This is a summary of […]
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023 Recorded First Quarter Revenue of $37.7 Million Signed $36 Million in.
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) – Equities research analysts at KeyCorp lowered their FY2024 earnings per share estimates for shares of Avid Bioservices in a report released on Wednesday, June 21st. KeyCorp analyst P. Knight now forecasts that the biopharmaceutical company will earn ($0.07) per share for the year, down from their previous […]